Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus

Block, 1975, Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets, Am. J. Med., 59, 533, 10.1016/0002-9343(75)90261-2 Deapen, 1992, A revised estimate of twin concordance in systemic lupus erythematosus, Arthritis Rheum., 35, 311, 10.1002/art.1780350310 Lawrence, 1987, A family survey of lupus erythematosus. 1. Heritability, J. Rheumatol., 14, 913 Hochberg, 1987, The application of genetic epidemiology to systemic lupus erythematosus, J. Rheumatol., 14, 867 Tsao, 2015, The role of Epstein–Barr virus in epithelial malignancies, J. Pathol., 235, 323, 10.1002/path.4448 Carbone, 2018, Epstein barr virus-associated hodgkin lymphoma, Cancers, 10, 163, 10.3390/cancers10060163 Rochford, 2015, Burkitt's lymphoma, Curr. Top. Microbiol. Immunol., 390, 267 Pender, 2014, Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy, Clin Transl Immunology, 3, e27, 10.1038/cti.2014.25 James, 1997, An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus, J. Clin. Invest., 100, 3019, 10.1172/JCI119856 James, 2001, Systemic lupus erythematosus in adults is associated with previous Epstein‐Barr virus exposure, Arthritis Rheum., 44, 1122, 10.1002/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D Kang, 2004, Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus, J. Immunol., 172, 1287, 10.4049/jimmunol.172.2.1287 James, 1997, Lupus humoral autoimmunity after short peptide immunization, Ann. N. Y. Acad. Sci., 815, 124, 10.1111/j.1749-6632.1997.tb52054.x Gulley, 2001, Molecular diagnosis of Epstein-Barr virus-related diseases, J. Mol. Diagn., 3, 1, 10.1016/S1525-1578(10)60642-3 Gross, 2005, EBV and systemic lupus Eeythematosus: a new perspective, J. Immunol., 174, 6599, 10.4049/jimmunol.174.11.6599 Draborg, 2012, Epstein-Barr virus and systemic lupus erythematosus, Clin. Dev. Immunol., 370516 Hanlon, 2014, Systematic review and meta-analysis of the sero-epidemiological association between Epstein-Barr virus and systemic lupus erythematosus, Arthritis Res. Ther., 16, R3, 10.1186/ar4429 Rasmussen, 2015, Antibodies to early EBV, CMV, and HHV6 antigens in systemic lupus erythematosus patients, Scand. J. Rheumatol., 44, 143, 10.3109/03009742.2014.973061 Westergaard, 2015, Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies, BioMed Res. Int., 472174 Vista, 2017, Strong viral associations with SLE among Filipinos, Lupus Sci Med, 4, 10.1136/lupus-2017-000214 Poole, 2009, Aberrant Epstein–Barr viral infection in systemic lupus erythematosus, Autoimmun. Rev., 8, 337, 10.1016/j.autrev.2008.12.008 Jog, 2019, Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals, Ann. Rheum. Dis., 78, 1235, 10.1136/annrheumdis-2019-215361 McClain, 2005, Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry, Nat. Med., 11, 85, 10.1038/nm1167 McClain, 2006, An altered immune response to Epstein‐Barr nuclear antigen 1 in pediatric systemic lupus erythematosus, Arthritis Rheum., 54, 360, 10.1002/art.21682 Jog, 2018, Epstein barr virus interleukin 10 suppresses anti-inflammatory phenotype in human monocytes, Front. Immunol., 9, 2198, 10.3389/fimmu.2018.02198 Kaufman, 2003, Peptide mimics of a major lupus epitope of SmB/B′, Ann. N. Y. Acad. Sci., 987, 215, 10.1111/j.1749-6632.2003.tb06051.x Poole, 2008, Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments, J. Autoimmun., 31, 362, 10.1016/j.jaut.2008.08.007 Esen, 2012, Serologic response to Epstein-Barr virus antigens in patients with systemic lupus erythematosus: a controlled study, Rheumatol. Int., 32, 79, 10.1007/s00296-010-1573-4 Zandman‐Goddard, 2009, Exposure to Epstein–Barr Virus infection is associated with mild systemic lupus erythematosus disease, Ann. N. Y. Acad. Sci., 1173, 658, 10.1111/j.1749-6632.2009.04754.x Quan, 2010, Epstein‐Barr virus promotes interferon‐α production by plasmacytoid dendritic cells, Arthritis Rheum., 62, 1693, 10.1002/art.27408 Severa, 2013, EBV stimulates TLR‐ and autophagy‐dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape, Eur. J. Immunol., 43, 147, 10.1002/eji.201242552 Guthridge, 2020, Adults with systemic lupus exhibit distinct molecular phenotypes in a cross-sectional study, EClinicalMedicine, 20, 100291, 10.1016/j.eclinm.2020.100291 Hochberg, 1997, Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus, Arthritis Rheum., 40, 1725, 10.1002/art.1780400928 Gladman, 2002, Systemic lupus erythematosus disease activity index 2000, J. Rheumatol., 29, 288 Munroe, 2014, Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare, Arthritis Rheum., 66, 1888, 10.1002/art.38573 Draborg, 2016, How compelling are the data for Epstein–Barr virus being a trigger for systemic lupus and other autoimmune diseases?, Curr. Opin. Rheumatol., 28, 398, 10.1097/BOR.0000000000000289 Chen, 2005, High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies, J. Rheumatol., 32, 44 Goodbourn, 2000, Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures, J. Gen. Virol., 81, 2341, 10.1099/0022-1317-81-10-2341 Berner, 2005, Phenotypic and functional analysis of EBV-specific memory CD8 cells in SLE, Cell. Immunol., 235, 29, 10.1016/j.cellimm.2005.06.010 Draborg, 2014, Reduced response to Epstein–Barr virus antigens by T-cells in systemic lupus erythematosus patients, Lupus Sci Med, 1, 10.1136/lupus-2014-000015 Larsen, 2011, Exhausted cytotoxic control of Epstein-Barr virus in human lupus, PLoS Pathog., 7, 10.1371/journal.ppat.1002328 Draborg, 2016, Impaired cytokine responses to epstein-barr virus antigens in systemic lupus erythematosus patients, J Immunol Res, 6473204 Draborg, 2013, Epstein-Barr virus in systemic autoimmune diseases, Clin. Dev. Immunol., 535738 Yap, 2019, B cell abnormalities in systemic lupus erythematosus and lupus nephritis—role in pathogenesis and effect of immunosuppressive treatments, Int. J. Mol. Sci., 20, 6231, 10.3390/ijms20246231 Sabbatini, 1993, Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein‐Barr virus‐encoded nuclear antigen EBNA I, Eur. J. Immunol., 23, 1146, 10.1002/eji.1830230525 James, 1992, Linear epitope mapping of an Sm B/B’ polypeptide, J. Immunol., 148, 2074, 10.4049/jimmunol.148.7.2074 McClain, 2003, Infectious mononucleosis patients temporarily recognize a unique, cross‐reactive epitope of Epstein‐Barr virus nuclear antigen‐1, J. Med. Virol., 70, 253, 10.1002/jmv.10385 Eloranta, 2009, Regulation of the interferon‐α production induced by RNA‐containing immune complexes in plasmacytoid dendritic cells, Arthritis Rheum., 60, 2418, 10.1002/art.24686 Båve, 2003, FcγRIIa is expressed on natural IFN-α-producing cells (plasmacytoid dendritic cells) and is required for the IFN-α production induced by apoptotic cells combined with lupus IgG, J. Immunol., 171, 3296, 10.4049/jimmunol.171.6.3296 Means, 2005, Human lupus autoantibody–DNA complexes activate DCs through cooperation of CD32 and TLR9, J. Clin. Invest., 115, 407, 10.1172/JCI23025 Banchereau, 2016, Personalized immunomonitoring uncovers molecular networks that stratify lupus patients, Cell, 165, 551, 10.1016/j.cell.2016.03.008 Ramos-Casals, 2012, B-cell-depleting therapy in systemic lupus erythematosus, Am. J. Med., 125, 327, 10.1016/j.amjmed.2011.09.010